References
- Fujihara K. Neuromyelitis optica spectrum disorders. Curr Opin Neurol. 2019;32(3):385–394. doi:10.1097/WCO.0000000000000694
- Mealy MA, Wingerchuk DM, Greenberg BM, et al. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol. 2012;69(9):1176–1180. doi:10.1001/archneurol.2012.314
- Ghezzi A, Bergamaschi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic’s neuromyelitis optica. J Neurol. 2004;251(1):47–52. doi:10.1007/s00415-004-0271-0
- Kim SH, Kim W, Li XF, et al. Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology. 2012;78(15):1179–1185. doi:10.1212/WNL.0b013e31824f8069
- Carnero Contentti E, Daccach Marques V. Soto de Castillo I, et al. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort. J Neurol. 2020;267(5):1260–1268. doi:10.1007/s00415-020-09699-2
- Akaishi T, Nakashima I, Takeshita T, et al. Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica. J Neuroimmunol. 2016;293:28–33. doi:10.1016/j.jneuroim.2016.02.004
- Collongues N, Marignier R, Jacob A, et al. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. Mult Scler. 2013;20(8):1086–1094. doi:10.1177/1352458513515085
- Cai L, Zhang Q, Zhang Y, et al. Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2020;46:102515. doi:10.1016/j.msard.2020.102515
- Fragoso Y, Ruocco H, Dias R, et al. Late onset of neuromyelitis optica spectrum disorders. Neurol Ther. 2019;8(2):477–482. doi:10.1007/s40120-019-0143-2
- Seok J, Cho H, Ahn S, et al. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: a multicenter retrospective study in Korea. Mult Scler. 2017;23(13):1748–1756. doi:10.1177/1352458516685416
- Zhang L, Yang L, Li T, et al. Distinctive characteristics of early-onset and late-onset neuromyelitis optica spectrum disorders. J Neurosci. 2016;127(4):334–338.
- Sepulveda M, Delgado-García G, Blanco Y, et al. Late-onset neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2019;6(6):1–9. doi:10.1212/NXI.0000000000000607
- Mao Z, Yin J, Zhong X, et al. Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population. BMC Neurol. 2015;15(1):1–7. doi:10.1186/s12883-015-0417-y
- Wingerchuk D, Banwell B, Bennett J, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189. doi:10.1212/WNL.0000000000001729
- Song H, Zhou H, Yang M, et al. Different characteristics of aquaporin-4 and myelin oligodendrocyte glycoprotein antibody-seropositive male optic neuritis in China. J Ophthalmol. 2019;2019:1–7. doi:10.1155/2019/4015075
- Grover S, Fishman G, Anderson R, et al. Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older. Ophthalmology. 1999;106(9):1780–1785. doi:10.1016/S0161-6420(99)90342-1
- McAnany J, Genead M, Walia S, et al. Visual acuity changes in patients with Leber congenital amaurosis and mutations in CEP290. JAMA Ophthalmol. 2013;131(2):178–182. doi:10.1001/2013.jamaophthalmol.354
- Thongmee W, Padungkiatsagul T, Jindahra P, et al. Prognostic factors for visual outcomes following the first episode of NMOSD-related optic neuritis in affected eyes. Clin Ophthalmol. 2020;14:4271–4278. doi:10.2147/OPTH.S285443
- Kim H, Park K, Oh S, et al. Association of optic neuritis with neuromyelitis optica spectrum disorder and multiple sclerosis in Korea. Korean J Ophthalmol. 2019;33(1):82–90. doi:10.3341/kjo.2018.0050
- Chen C-Y, Huang EJ-C, Kuo C-N, et al. The relationship between age, axial length and retinal nerve fiber layer thickness in the normal elderly population in Taiwan: the Chiayi eye study in Taiwan. PLoS One. 2018;13(3):1–13.
- Celebi ARC, Mirza GE. Age related change in retinal nerve fiber layer thickness measured with spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54(13):8095–8103. doi:10.1167/iovs.13-12634
- Jindahra P, Hengsiri N, Witoonpanich P, et al. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer’s disease using optical coherence tomography. Clin Ophthalmol. 2020;14:2995–3000. doi:10.2147/OPTH.S276625
- Wick G, Grubeck-Loevenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol. 1997;32(4–5):401–413. doi:10.1016/S0531-5565(96)00152-0